Robert Schoenleber
Bayer (United States)(US)Bayer (Germany)(DE)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Melanoma and MAPK Pathways, Synthesis and biological activity, Carbohydrate Chemistry and Synthesis, Peroxisome Proliferator-Activated Receptors
Most-Cited Works
- → Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in Vivo(1997)1,062 cited
- → Quinazolinone Derivatives as Orally Available Ghrelin Receptor Antagonists for the Treatment of Diabetes and Obesity(2007)157 cited
- → A-77636: a potent and selective dopamine D1 receptor agonist with antiparkinsonian activity in marmosets(1992)156 cited
- → A68930: a potent agonist selective for the dopamine D1 receptor(1991)88 cited
- → Synthesis and dopaminergic activity of 3-substituted 1-(aminomethyl)-3,4-dihydro-5,6-dihydroxy-1H-2-benzopyrans: characterization of an auxiliary binding region in the D1 receptor(1991)63 cited
- → Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists: Synthesis, Structure−Activity Relationship, and In Vivo Efficacy(2007)53 cited
- → 1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors(2000)53 cited
- → (1R,3S)-1-(Aminomethyl)-3,4-dihydro-5,6-dihydroxy-3-phenyl-1H-2-benzopyran: a potent and selective D1 agonist(1990)50 cited
- → Discovery of a new class of p38 kinase inhibitors(2000)47 cited
- → Chromopeptides from phycoerythrins. Structure and linkage of a phycoerythrobilin tryptic tripeptide derived from a B-phycoerythrin(1983)40 cited